All Sauce from Weekly Sauce:

A new drug to treat Alzheimer’s disease was approved by the U.S. Food and Drug Administration on Tuesday. In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including swelling and bleeding in the brain. “Kisunla…  read on >  read on >

Simple exercises performed during rounds of chemotherapy can help people avoid nerve damage normally associated with the cancer-killing drugs, a new study suggests. About twice as many cancer patients on chemo wound up with long-lasting nerve damage if they didn’t exercise, compared with two groups assigned different exercise regimens, researchers reported July 1 in the…  read on >  read on >

Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide had 50% to 56% decreased odds for either becoming alcoholic or relapsing into alcoholism, researchers reported recently in the journal Nature Communications. Few drugs are now available to treat alcohol use disorder (AUD), so adding semaglutide to…  read on >  read on >

A girl’s genetics can indirectly influence the age when she has her first period, by accelerating her weight gain in childhood, a new study finds. A number of other genes also can directly affect the age of puberty, some with profound effects, researchers added. More than 1,000 genetic variants are tied to the age of…  read on >  read on >